PolyMedix

PolyMedix

PolyMedix

PolyMedix develops small molecule compounds for the treatment of acute cardiovascular disorders and infectious diseases.
Founded
2002
Raised
$14M
Follow us
Alexa global traffic share
Latest funding
$14,000,000
Venture capital - 2010
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when PolyMedix makes some noise.